| __timestamp | Amneal Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 785623000 | 122045000 |
| Thursday, January 1, 2015 | 866280000 | 144427000 |
| Friday, January 1, 2016 | 1018225000 | 215003000 |
| Sunday, January 1, 2017 | 1033654000 | 302238000 |
| Monday, January 1, 2018 | 1662991000 | 408897000 |
| Tuesday, January 1, 2019 | 1626373000 | 392755000 |
| Wednesday, January 1, 2020 | 1992523000 | 520397000 |
| Friday, January 1, 2021 | 2093669000 | 579775000 |
| Saturday, January 1, 2022 | 2212304000 | 667238000 |
| Sunday, January 1, 2023 | 2393607000 | 607521000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. have showcased remarkable revenue trajectories over the past decade. From 2014 to 2023, Amneal Pharmaceuticals experienced a robust growth, with revenues surging by over 200%, peaking at approximately $2.4 billion in 2023. This growth reflects their strategic expansions and product innovations.
Conversely, Supernus Pharmaceuticals, while smaller in scale, demonstrated a steady upward trend, with revenues increasing by more than 400% during the same period, reaching around $607 million in 2023. This impressive growth underscores their focus on niche markets and effective product launches.
The data highlights a fascinating contrast: Amneal's larger scale and rapid growth versus Supernus's agile and focused expansion. As the pharmaceutical industry continues to evolve, these companies exemplify diverse strategies for success.
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Revenue Insights: Gilead Sciences, Inc. and Supernus Pharmaceuticals, Inc. Performance Compared
Alnylam Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: BeiGene, Ltd. vs Supernus Pharmaceuticals, Inc.
Exelixis, Inc. and Amneal Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: TG Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.?
Revenue Insights: Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Performance Compared
Amneal Pharmaceuticals, Inc. vs MorphoSys AG: Examining Key Revenue Metrics
Revenue Showdown: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Amneal Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Revenue Insights: Amneal Pharmaceuticals, Inc. and Novavax, Inc. Performance Compared
Comparing Revenue Performance: Supernus Pharmaceuticals, Inc. or Evotec SE?